2-Aminopyrimidine TLR8 Modulators With Higher Selectivity
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current regulators for Toll-like receptor 8 (TLR8) lack high activity, selectivity, and have poor pharmacokinetics, limiting their effectiveness in treating a wide range of diseases.
Innovation Solution
Development of 2-aminopyrimidine compounds with specific structural modifications, particularly in the R2 position, to enhance activity, selectivity, and safety as TLR8 modulators.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current TLR8 regulators are used, then immune response activation is achieved, but activity and selectivity are insufficient
Solution Approach 1:
The patent applies parameter changes by systematically modifying chemical structure parameters of TLR8 regulators, specifically optimizing substituents at different positions (R1-R6, X, Y, Z) to achieve enhanced activity and selectivity. The structural formula I with variable parameters allows fine-tuning of molecular properties to improve therapeutic effectiveness while maintaining TLR8 activation capability.
2Reliability
If TLR8 activation is enhanced, then therapeutic benefits are improved, but toxicity may increase
Solution Approach 1:
The patent applies local quality by introducing specific substituent groups at particular positions (R1-R6) of the TLR8 regulator structure, where each position can be independently optimized. This allows enhancement of therapeutic activity at specific molecular regions while maintaining safety profiles, achieving high activity with low toxicity through localized structural modifications.
3Reliability
If structural modifications are made to improve activity, then selectivity increases, but synthesis complexity increases
Solution Approach 1:
The patent applies segmentation by dividing the TLR8 regulator molecule into distinct functional segments (R1-R6 substituents, core structure with X, Y, Z variables). Each segment can be independently optimized for selectivity while being synthesized separately and assembled, reducing overall synthesis complexity. The modular structure allows systematic optimization without requiring complete redesign of the entire molecule.
Data Source
AI summary
2-aminopyrimidine compounds and pharmaceutical compositions and uses thereof are provided. Specifically, the 2-aminopyrimidine compounds have a structure as shown in formula I. The compounds are suitable for use in the fields of anti-virus and anti-infection, as well as treatment of diseases such as autoimmune diseases and tumors.